Paper36029463
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.
Zhang L and 25 others. Circulation, 2022. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction. Papers, record 36029463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36029463
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Ventricular Dysfunction, Left | Major topic |
| Humans | |
| Stroke Volume | |
| Proteomics | |
| Biomarkers |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42791324 | Cardiac proteomic and phosphoproteomic profiling defines clinically relevant molecular subgroups in human heart failure. | Nat Cardiovasc Res | 2026 | https://conductscience.org/library/papers/42791324 | PubMed |
| 42737484 | Aptamer-Based Platforms for Human Aging Biomarkers: Multiplexed Proteomics, Biosensors and Translational Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737484 | PubMed |
| 42335150 | Proteomics risk scores and mortality in heart failure: Generalizability across populations. | PLoS One | 2026 | https://conductscience.org/library/papers/42335150 | PubMed |
| 42290908 | Beyond eGFR and Albuminuria: Biological Pathways and Multiomics in Cardiovascular-Kidney-Metabolic Disease. | Kidney Int Rep | 2026 | https://conductscience.org/library/papers/42290908 | PubMed |
| 41906877 | Dietary Sodium-Regulated Plasma SVEP1 and Inverse Salt Sensitivity. | Hypertension | 2026 | https://conductscience.org/library/papers/41906877 | PubMed |
| 41309604 | Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies. | Nat Commun | 2025 | https://conductscience.org/library/papers/41309604 | PubMed |
| 40745245 | Unsupervised Learning Based on Proteomic Signatures Identifies Distinct Subgroups of Heart Failure With Mildly Reduced Ejection Fraction. | J Cardiovasc Transl Res | 2025 | https://conductscience.org/library/papers/40745245 | PubMed |
| 40675975 | Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy. | Nat Commun | 2025 | https://conductscience.org/library/papers/40675975 | PubMed |
| 40504107 | Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/40504107 | PubMed |
| 40355922 | Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40355922 | PubMed |
| 40230291 | Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure. | Eur J Heart Fail | 2025 | https://conductscience.org/library/papers/40230291 | PubMed |
| 40066352 | Comprehensive bioinformatics analysis of hub genes in ischemic heart failure and atrial fibrillation. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40066352 | PubMed |
| 40063168 | Clinical Insights from Proteomics in Heart Failure. | Curr Heart Fail Rep | 2025 | https://conductscience.org/library/papers/40063168 | PubMed |
| 39895831 | Deep plasma and tissue proteome profiling of knockout mice reveals pathways associated with Svep1 deficiency. | J Mol Cell Cardiol Plus | 2025 | https://conductscience.org/library/papers/39895831 | PubMed |
| 39831317 | Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP. | Circ Heart Fail | 2025 | https://conductscience.org/library/papers/39831317 | PubMed |
| 38904251 | Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38904251 | PubMed |
| 38766848 | Using Omics to Identify Novel Therapeutic Targets in Heart Failure. | Circ Genom Precis Med | 2024 | https://conductscience.org/library/papers/38766848 | PubMed |
| 38757788 | Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification. | Eur Heart J | 2024 | https://conductscience.org/library/papers/38757788 | PubMed |
| 38516784 | Incremental Value of a Metabolic Risk Score for Heart Failure Mortality: A Population-Based Study. | Circ Genom Precis Med | 2024 | https://conductscience.org/library/papers/38516784 | PubMed |
| 38420755 | Proteomic Associations of Adverse Outcomes in Human Heart Failure. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38420755 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36029463
GET https://conductscience.org/api/papers/v1/36029463/authors?page=2